subscribeSubscribe
GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids

GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids
PINKSHEET
27 Aug 2020
Share Share
GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma

GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma
BUSINESSWIRE
27 Feb 2020
Share Share
Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs

Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
Michael Erman CNBC
01 Jan 2020
Share Share
GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma

GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma
BUSINESSWIRE
03 Oct 2019
Share Share
FDA knocks back AstraZeneca`s respiratory ambitions

FDA knocks back AstraZeneca`s respiratory ambitions
J.Gardner BIOPHARMADIVE
02 Oct 2019
Share Share
AstraZeneca`s combo lung disease therapy fails to win FDA approval

AstraZeneca`s combo lung disease therapy fails to win FDA approval
A. Jagadeesh REUTERS
02 Oct 2019
Share Share
Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma

Phase III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma
BUSINESSWIRE
03 May 2019
Share Share
GSK chases Trelegy asthma nod with mixed phase 3 results

GSK chases Trelegy asthma nod with mixed phase 3 results
Kyle Blankenship FIERCE PHARMA
03 May 2019
Share Share
Ph III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary

Ph III CAPTAIN Study of Trelegy Ellipta in Patients with Asthma Meets Primary
BUSINESSWIRE
02 May 2019
Share Share
Teva closes in on $3B cost-cutting goal

Teva closes in on $3B cost-cutting goal
Eric Sagonowsky FIERCE PHARMA
02 May 2019
Share Share